PharmacyCodes



Novobiocinum [Inn-Latin] en es it fr

Novobiocinum [Inn-Latin] Brand names, Novobiocinum [Inn-Latin] Analogs

Novobiocinum [Inn-Latin] Brand Names Mixture

  • Albacillin Suspension (Novobiocin (Novobiocin Sodium) + Penicillin G Procaine)
  • Delta-Albaplex Tablets (Novobiocin (Novobiocin Sodium) + Prednisolone + Tetracycline Hydrochloride)
  • Novodry Plus Suspension (Novobiocin (Novobiocin Sodium) + Penicillin G Procaine)
  • Special Formula 17900-Forte Suspension (Dihydrostreptomycin (Dihydrostreptomycin Sulfate) + Hydrocortisone Acetate + Hydrocortisone Sodium Succinate + Novobiocin (Novobiocin Sodium) + Penicillin G Procaine + Polymyxin B Sulfate)

Novobiocinum [Inn-Latin] Chemical_Formula

C31H36N2O11

Novobiocinum [Inn-Latin] RX_link

No information avaliable

Novobiocinum [Inn-Latin] fda sheet

Novobiocinum [Inn-Latin] msds (material safety sheet)

Novobiocinum_[Inn-Latin] MSDS

Novobiocinum [Inn-Latin] Synthesis Reference

No information avaliable

Novobiocinum [Inn-Latin] Molecular Weight

612.624 g/mol

Novobiocinum [Inn-Latin] Melting Point

No information avaliable

Novobiocinum [Inn-Latin] H2O Solubility

Insoluble

Novobiocinum [Inn-Latin] State

Solid

Novobiocinum [Inn-Latin] LogP

2.737

Novobiocinum [Inn-Latin] Dosage Forms

Drug premix; Suspension

Novobiocinum [Inn-Latin] Indication

For the treatment of infections due to staphylococci and other susceptible organisms

Novobiocinum [Inn-Latin] Pharmacology

Novobiocin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.

Novobiocinum [Inn-Latin] Absorption

No information avaliable

Novobiocinum [Inn-Latin] side effects and Toxicity

No information avaliable

Novobiocinum [Inn-Latin] Patient Information

No information avaliable

Novobiocinum [Inn-Latin] Organisms Affected

Enteric bacteria and other eubacteria